Ulrich Wandschneider - 18 Mar 2026 Form 3 Insider Report for BioNTech SE (BNTX)

Reporting relationship: Director
Issuer ticker: BNTX
Reported as of: 18 Mar 2026
Net transaction value: $0
SEC form: 3
Accepted by SEC: 18 Mar 2026, 17:33:41 UTC
Source filing: View source filing
Reporting owner signature: /s/ Humza Bokhari, Attorney-in-Fact

Key filing fact

Ulrich Wandschneider filed Form 3 for BioNTech SE (BNTX) on 18 Mar 2026.

Key facts

This page summarizes Ulrich Wandschneider's Form 3 filing for BioNTech SE (BNTX).
0 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 18 Mar 2026, 17:33.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002118992 Primary reporting owner

Wandschneider Ulrich

Relationship: Director
Address: C/O BIONTECH SE, AN DER GOLDGRUBE 12, MAINZ, GERMANY
Signature: /s/ Humza Bokhari, Attorney-in-Fact
Signature date: 18 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BNTX holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,927
Date: 18 Mar 2026
Ownership: See Footnote
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The ordinary shares are held by beebusy Capital GmbH. The Reporting Person is the sole shareholder of beebusy Capital GmbH and may be deemed to beneficially own the ordinary shares held by beebusy Capital GmbH.

SEC remarks

Exhibit List - Exhibit 24 - Power of Attorney